| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Mexico | 3 | |
| #2 | Brazil | 2 | |
| #3 | Canada | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | China | 1 | |
| #7 | Costa Rica | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Nicaragua | 1 | |
| #10 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Estrada Flores Luis | 8 |
| #2 | Flores Luis Estrada | 4 |
| #3 | Maya Ayala Kenia Lizeth | 4 |
| #4 | Mohar Betancourt Alejandro | 4 |
| #5 | Rivera Hernandez Alfredo | 4 |
| #6 | Duenas Gonzalez Alfonso | 4 |
| #7 | Borbolla Garcia Arturo | 4 |
| #8 | Serna Martinez Raul | 4 |
| #9 | Luis Estrada Flores | 3 |
| #10 | Hernandez Alfredo Rivera | 2 |
| Publication | Filing date | Title |
|---|---|---|
| MX2008014321A | Process for obtaining a composition of rosuvastatin calcium and product obtained. | |
| MX2007015202A | Sprayûtalc composition containing terbinafine and triclosan. | |
| CA2579220A1 | Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment | |
| KR20070061833A | Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment |